PharmaTalkRadio

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about formulation and physical approaches to achieve targeted brain delivery. The panelists discuss challenges and updates, patient acceptability and recent approvals for a variety of approaches including: Nose-to-brain delivery Introcerebroventricular injections Blood-brain-barrier disruption vi...

Summary:  This podcast covers how a co-creation and collaboration was formed between Abbott, the National Blood Clot Alliance and Luminous to gather qualitative insights exploring motivations in a key patient population for participating in clinical research.  The podcast additionally covers how the partnership has influenced patient engagement in a large healthcare organization, the resulting shi...

This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about the technical innovation in the vaccine space within R&D over the past several years as well as the challenges and opportunities around the uptake and implementation of these technologies. Specifically: Barriers to implementation of technological advancements How the vaccine marketplace...

Summary: In this podcast, PALADIN Consortium Committee Co-Chairs, Deirdre BeVard of CSL and Dr Len Valentino of World Federation of Hemophilia USA, discuss how the pre-competitive group is creating resources aimed at enhancing and speeding up industry-patient advocacy collaborations.  For more information on PharmaTalk Radio podcasts, you can go to theconferenceforum.org . For more information on...

CMOs play a critical role in ensuring activities prior to approval lead to a successful launch. In this podcast, originally recorded as a session at the 2024 CMO Summit 360°, panelists discuss the role of the CMO in preparing for a new product launch, including planning, timing, activities and hiring prior to PDUFA, including: The timing and strategy of building out medical affairs Strategic imper...

Valerie Bowling, Executive Director of Patients as Partners Europe conference, discusses what attendees can expect at the 9th annual conference, including key topic areas, session highlights, presenting companies and more. For more information about the upcoming event, full agenda and speakers, visit  https://patientsaspartnerseu.com/

Summary: In this podcast, recorded at the 2024 Clinical Research as a Care Option (CRAACO) event, Donna O'Brien, Manatt Health, Trevan Locke, Duke-Margolis, and Denise Snyder, Duke University School of Medicine, discuss the financial barriers to getting coverage for clinical trials, coverage by sponsors vs standard of care and new developments for the audience to be aware of.  They also cover:  Wh...

Summary: Dr David Levitz, Medical Director of the Early Phase Program at Montefiore Einstein Cancer Center, talks about how the center has been able to offer its community access to early stage clinical research.  Dr Levitz brings the audience through the necessary infrastructure, dedicated team, interdepartmental collaboration, higher-up support, recruitment and partnership strategies required to...

Summary: In this podcast, recorded at the February 2024 IO360º summit, biopharma, finance and investment experts discuss the fundability features of IO biotechs, and the current pharma needs that will drive potential partnerships or M&A.  Moderater: Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics Panelists:  Irina Margine, PhD, Principal, Biotech Private Equity, Wellington Management Kha...

This podcast features a panel discussion with pharma and biotech leaders about the past and future direction of pulmonary delivery of biologics. Specifically, the panelists discuss: The benefits and costs of different formulation approaches to deliver inhaled therapeutics what needs to be developed to enable more biologics Different device approaches including nebulizers, soft mist inhalers, dry p...

As companies evolve, hiring is essential, sometimes while concurrently downsizing other areas of the company. In this podcast, originally recorded as a session at the 2024 CMO Summit 360°, panelists discuss how to scale up with effective budgeting in mind including: Determining the priority of roles/functions Balancing between outsourcing, contracting consultants and hiring internally Key hires fo...

Summary: In this podcast from the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research, Boehringer Ingelheim's Candice Fitzgerald, MMedSc, shares how the organization built collaborative partnerships across functions to drive faster and more informed clinical development and launch readiness.  Specifically, she covers: Deploying a more holistic, strategic approach to deliver on clinica...

This podcast features a panel discussion with payers, investors and consultants about how they approach decisions to cover new medications and the role novel delivery approaches play in that decision-making from the 2024 PODD: Partnership Opportunities in Drug Delivery Conference. The panelists discuss the growing number of self-insured employers that are considering restricting drugs based on cos...

This podcast features a panel discussion on how to engage patients throughout the development process with biotech CMOs and representatives from Legacy Health Strategies, Sano Genetics and Tasso, from the 2025 Chief Medical Officer Summit 360°. The panelists discuss evaluating how early to engage patients, navigating potential challenges associated with patient engagement both in earlier and later...

For more information, visit theconferenceforum.org 

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical operations experts into the decision-making process can help proactively address some of the biggest challenges facing trials today. In this podcast, Raul Lima, MBA, EVP, Strategic Clinical Operations of...

For more information, go to theconferenceforum.org 

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and AbbVie From the 2024 PODD: Partnership Opportunities in Drug Delivery. The panelists discuss unique and compelling challenges of the last mile for LMICs, the role of pharma and medtech in the evoluti...

For more information, go to CRAACOevent.com or realtime-eclinical.com

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org. 

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org

For more information, go to theconferenceforum.org

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deli...